NO20082837L - Isotopmerkede benzotiazolforbindelser som avbildningsmidler for amyloidogene proteiner - Google Patents

Isotopmerkede benzotiazolforbindelser som avbildningsmidler for amyloidogene proteiner

Info

Publication number
NO20082837L
NO20082837L NO20082837A NO20082837A NO20082837L NO 20082837 L NO20082837 L NO 20082837L NO 20082837 A NO20082837 A NO 20082837A NO 20082837 A NO20082837 A NO 20082837A NO 20082837 L NO20082837 L NO 20082837L
Authority
NO
Norway
Prior art keywords
isotope
imaging agents
benzothiazole compounds
amyloidogenic proteins
labeled
Prior art date
Application number
NO20082837A
Other languages
English (en)
Norwegian (no)
Inventor
Jr Chester A Mathis
William E Klunk
Original Assignee
Univ Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pittsburgh filed Critical Univ Pittsburgh
Publication of NO20082837L publication Critical patent/NO20082837L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C07D277/66Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20082837A 2005-12-01 2008-06-26 Isotopmerkede benzotiazolforbindelser som avbildningsmidler for amyloidogene proteiner NO20082837L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74106705P 2005-12-01 2005-12-01
PCT/US2006/045807 WO2007064773A2 (en) 2005-12-01 2006-11-30 Isotopically-labeled benzothiazole compounds as imaging agents for amyloidogenic proteins

Publications (1)

Publication Number Publication Date
NO20082837L true NO20082837L (no) 2008-08-28

Family

ID=37981903

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082837A NO20082837L (no) 2005-12-01 2008-06-26 Isotopmerkede benzotiazolforbindelser som avbildningsmidler for amyloidogene proteiner

Country Status (10)

Country Link
US (1) US20090142269A1 (pt)
EP (1) EP1971584A2 (pt)
JP (1) JP2009519239A (pt)
CN (1) CN101351458A (pt)
AU (1) AU2006320556A1 (pt)
BR (1) BRPI0619251A2 (pt)
CA (1) CA2631905A1 (pt)
NO (1) NO20082837L (pt)
RU (1) RU2008126463A (pt)
WO (1) WO2007064773A2 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101355940B (zh) * 2005-09-16 2013-03-27 匹兹堡大学高等教育联邦体系 用于检测具有至少一种促淀粉样变蛋白的淀粉样沉积物的体内或体外方法
FR2916762B1 (fr) * 2007-05-31 2013-11-15 Biomerieux Sa Nouveaux substrats enzymatiques de nitroreductase
MX2009013332A (es) 2007-06-08 2010-01-25 Mannkind Corp Inhibidores de ire-1 alfa.
RU2475267C2 (ru) * 2007-08-30 2013-02-20 Джи-И Хелткер Лимитед Радиофармацевтическая композиция
US8354400B2 (en) 2008-09-26 2013-01-15 Eisai R&D Co., Ltd. Benzoxazole compounds and methods of use
BRPI0919816A2 (pt) * 2008-09-26 2019-09-24 Eisai R&D Man Co Ltd uso compostos benzoxazólicos no tratamento de malária
GB0821994D0 (en) * 2008-12-02 2009-01-07 Ge Healthcare Ltd In viva imaging method
KR101123178B1 (ko) * 2009-04-09 2012-06-13 (주)에스메디 2-아릴벤조싸이오펜 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 퇴행성 뇌질환의 진단 또는 치료용 약학적 조성물
WO2011100396A2 (en) * 2010-02-10 2011-08-18 Trustees Of Boston University Serum clusterin levels in systemic amyloidosis featuring cardiomyopathy
CN102558091B (zh) * 2011-12-22 2014-10-08 合肥工业大学 一种苯并噻唑类衍生物及其用途
DK2767532T3 (en) 2012-12-21 2016-09-12 Nat Inst For Quantum And Radiological Science And Tech New connection for reproduction of tau protein heavy in the brain.
CN102977051B (zh) * 2012-12-24 2015-06-10 湖南大学 一种合成2-取代苯并噻唑衍生物的方法
JP2016079108A (ja) * 2014-10-10 2016-05-16 国立大学法人京都大学 放射性ヨウ素標識スチリル置換芳香族ヘテロ環化合物
GB201617339D0 (en) 2016-10-12 2016-11-23 Lytix Biopharma As Therapeutic compounds
TW201946624A (zh) 2018-05-09 2019-12-16 新旭生技股份有限公司 雜芳基化合物及其用途
SG11202109443QA (en) 2018-11-02 2021-09-29 Fount Bio Inc Crosslinked materials
US20220175819A1 (en) * 2019-04-19 2022-06-09 Fount Bio, Inc. Delivery and retention of active agents within the skin
CN114728071B (zh) 2019-11-13 2024-12-06 新旭生技股份有限公司 用于降解tau蛋白聚集体的化合物及其用途
CN111925343B (zh) * 2020-08-12 2021-11-23 石家庄四药有限公司 一种利奈唑胺降解杂质的合成方法
WO2022159436A1 (en) * 2021-01-19 2022-07-28 Cold Spring Harbor Laboratory Inhibitors of dyrk and pim

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666829A (en) * 1985-05-15 1987-05-19 University Of California Polypeptide marker for Alzheimer's disease and its use for diagnosis
US5231000A (en) * 1987-10-08 1993-07-27 The Mclean Hospital Antibodies to A4 amyloid peptide
US6168776B1 (en) * 1994-07-19 2001-01-02 University Of Pittsburgh Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
US6001331A (en) * 1996-01-24 1999-12-14 Warner-Lambert Company Method of imaging amyloid deposits
RU2324686C2 (ru) * 2000-08-24 2008-05-20 Юнивесити Оф Питсбэг ПРОИЗВОДНЫЕ ТИОФЛАВИНА, СВЯЗЫВАЮЩИЕ АМИЛОИД, СПОСОБ ОБНАРУЖЕНИЯ in vivo ОТЛОЖЕНИЙ АМИЛОИДА И СПОСОБ РАСПОЗНАВАНИЯ БОЛЕЗНИ АЛЬЦГЕЙМЕРА
AU2003212490A1 (en) * 2002-02-13 2003-09-04 Amersham Plc Benzothiazole derivatives for in vivo imaging of amyloid plaques
CA2438032C (en) * 2003-03-14 2013-05-07 University Of Pittsburgh Benzothiazole derivative compounds, compositions and uses

Also Published As

Publication number Publication date
EP1971584A2 (en) 2008-09-24
JP2009519239A (ja) 2009-05-14
WO2007064773A3 (en) 2007-11-15
AU2006320556A1 (en) 2007-06-07
WO2007064773A2 (en) 2007-06-07
CA2631905A1 (en) 2007-06-07
RU2008126463A (ru) 2010-01-10
BRPI0619251A2 (pt) 2016-09-06
US20090142269A1 (en) 2009-06-04
AU2006320556A8 (en) 2008-07-31
CN101351458A (zh) 2009-01-21

Similar Documents

Publication Publication Date Title
NO20082837L (no) Isotopmerkede benzotiazolforbindelser som avbildningsmidler for amyloidogene proteiner
ATE526318T1 (de) Farnesoid-x-rezeptor-agonisten
NO20092611L (no) Krystallinsk faststoff Rasagilin base
CY1110026T1 (el) Ενωσεις πιπεραζινης βενζισοξαζολης και μεθοδοι χρησης εξ αυτων
EA200701918A1 (ru) Белок липокалин
CY1117615T1 (el) Ενωσεις θειαζολης σουλφοναμιδης και οξαζολης
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
EA200702643A1 (ru) Антитела, связывающие tweak
FR2889449B1 (fr) Preparations implantables
TW200732349A (en) Anti-OX40L antibodies and methods using same
CY1109998T1 (el) Ενδυναμωτες υποδοχεων γλουταμινικου
FI20065267L (fi) Järjestely dentaalikuvausta varten
NO20084821L (no) Formuleringer og metoder for celleimaging og terapi
TW200727920A (en) New regimens for oral monophasic contraceptives
EA200702529A1 (ru) Фунгицидная комбинация биологически активных веществ
SE0301650D0 (sv) Novel compounds
EA200801414A1 (ru) Кальцилитические соединения
TW200621160A (en) Anti-termite agent
EP1938808A4 (en) PREPARATION FOR TOPICAL APPLICATION
RU2012137206A (ru) Лигнангидроксилаза
ITTO20030850A1 (it) Procedimento per la preparazione di 4-ammino-3,5-dicloro-benzotrifloruro.
ITBO20030521A1 (it) Endoscopio per uso oculistico.
AP2006003603A0 (en) Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof.
GB0514743D0 (en) Salt
CL2004001156A1 (es) Procedimiento de preparacion de compuestos heterociclicos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application